Mindfully Curated
Sweden could become an important source of rare earth elements needed for magnets and green technologies. Instead of extracting one target metal, researchers are cataloging everything contained in Swedish mineral deposits. They will then develop magnet…
China’s Tianwen-1 orbiter captured a faint but remarkable view of 3I/ATLAS as the interstellar comet raced past Mars. The images reveal its tail and glowing coma, offering scientists a glimpse of material born beyond our solar system.
A newly identified fossil ape from northern Egypt is reshaping ideas about where the ancestors of modern apes first emerged. Analyses place it closer to living apes than any known East African species of the same age, pointing to North Africa and the M…
The longevity-linked APOE2 gene appears to protect brain cells by reducing DNA damage and helping neurons recover from stress. The finding could open a new path toward treatments that mimic APOE2’s defenses in people at higher genetic risk for Alzheime…
A large study suggests that GLP-1 drugs including Ozempic and Mounjaro may slightly increase the risk of hair loss in people with type 2 diabetes. Compared with two other common classes of diabetes medications, GLP-1 users had a significantly higher ra…
Fossils discovered in Japan more than two decades ago have finally been identified as a new genus and species of giant salamander. Limnospondylus ajimuensis lived around 3.5 million years ago in a warmer, wetter Kyushu and may have reached 1.1 meters i…
Revenue surged 23% YoY to $3.49B, driven by AI data center and industrial demand.
AI cloud orders hit 2.8 billion euros amid optical growth.
Record quarterly revenue and volume growth offset by fuel headwinds.
NVIDIA commands a 55% net margin and fortress balance sheet, while Planet Labs burns cash despite 26% revenue growth, a tale of profitability versus potential.
The team discusses the pros and cons of this new investment option for children.
Organic sales grew 4% as orders surged 16%, with backlog up 9% year over year.
Organic revenue beat guidance at 5% as pharma and biotech activity strengthened.
Rocket Lab stock is down 32% in July, but it’s still winning contracts.